Title: Dexamethasone plus lenalidomide in treatment of multiple myeloma
Abstract: Combination of lenalidomide with dexamethasone (LD) is of high effectiveness for treatment of multiple myeloma (MM), resulting in an improved overall survival, response rate, and time to progression in relapsed or refractory MM. Adverse events, especially venous thromboembolism, were generally well tolerated. In addition, lenalidomide plus dexamethasone is a potential therapy in maintenance of myeloma.
Publication Year: 2011
Publication Date: 2011-02-01
Language: en
Type: article
Indexed In: ['crossref']
Access and Citation
Cited By Count: 1
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot